Zotide Delivery Device Pen (Only Pen)

Overview Zotide Delivery Device Pen (Only Pen)

The Cipla-designed Zotide injection pen facilitates subcutaneous administration to the thigh or abdomen. This device requires a Zotide cartridge and Zotide pen needle for proper function. The prescribed dose is a single daily 80 µl injection (20 mcg teriparatide) into the thigh or abdomen. Intravenous or intramuscular use is unsupported by available data. Initial administration should occur in a setting allowing the patient to recline if orthostatic hypotension arises. Indicated for: osteoporosis treatment via injection. Product Details: Requires a Zotide cartridge and needle; simple injection into the abdomen or thigh. Directions: Follow package instructions. Precautions: Consult the product label; pregnant individuals should seek medical advice; keep out of children's reach; store in a cool, dry, and shaded area.

How to Use Zotide Delivery Device Pen (Only Pen):

Follow the instructions on the product label.

Safety Instruction of Zotide Delivery Device Pen (Only Pen):

• Always check the product label before administration.
• Expectant mothers should seek medical advice prior to use.
• Store where children cannot access.
• Keep in a cool, dry area, protected from sunlight.